Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stock Price

I have no idea whether S&L installed Pohl, and have never said so. However, it's obvious that Pohl got the position with S&L's consent.

Perhaps I have been titling at widmills lately, but I'm apparently much more content with all things PTSC than many, if not most here.

I've posted my "fantasy" scenarios, depicting what I believe makes sense and would be in everyone's best interest. But that's all "we'll see" stuff, much of it contingent on the Markman/current litigation.

Two things that do continue to baffle are the dividends, and that PTSC hasn't made a deal with S&L (themselves? LOL) to buy out the warrants. It looks like S&L wants to be rid of them. PTSC has stated their intent for share buy-back (i.e., increased ownership). It seems these two objectives meet, but are not acted upon. That's my big head-scratcher.

I probably can't figure it out 'cuz I KNOW nuttin'!

SGE

Share
New Message
Please login to post a reply